The top story of the day was President Donald Trump’s comments about cannabis. Cannabis Business Times This month, readers didn’t want to miss it.
Trump finally broke his silence regarding cannabis reform at a White House news conference held on Aug. 11th, nearly seven months after he was inaugurated. You can tell them by clicking on the link reporters “we’re looking at that,” and “we’ll make a determination … over the next few weeks.”
Trump looked back at Pam Bondi, the Attorney General of Florida when he spoke about the timeline for determining whether or not to proceed with the proposed rule that would reclassify marijuana from Schedule I drug to Schedule III under the Controlled Substances Act.
Under President Joe Biden’s leadership, the current hearing rescheduling process was initiated. Stayed Since early January, the case has been in limbo pending a resolution to an interlocutory appellation.
Trump could choose to restart the hearings under a newly appointed Drug Enforcement Administration (DEA), move ahead with the proposed rule immediately without a hearing by going straight to a rule final, begin from scratch and conduct a scientific and medical evaluation under the U.S. Department of Health and Human Services or scrap the entire reform package.
Taken the No. Taken the No. CBT’s One of the 10 most popular articles in this month’s list was an article about U.S. House Rep. Greg Steube. Filing legislation to reclassify cannabis to a Schedule III substance—the Marijuana 1-to-3 Act—the day after Trump’s comments.
Steube The following are some of the ways to get in touch with each other. “It’s even more absurd to classify cocaine as being less restricted than marijuana.”
Some of the other articles readers were not willing to miss in August include those about the Texas Senate нлину крку Massachusetts AYR Wellness introduces another bill banning hemp THC during a special second session. A well-known attorney reveals that he was a thief alerted New York’s cannabis regulators realized more than a decade ago that their buffer zone measurements between schools and dispensaries were incorrect.
Don’t miss out on our Top 10 stories After August 2025,
Donald Trump’s remarks on marijuana rescheduling were the most popular story that trended. Cannabis Business Times This month, readers didn’t want to miss it.
Trump finally broke his silence regarding cannabis reform at a White House news conference held on Aug. 11th, nearly seven months after he was inaugurated. You can tell them by clicking on the link reporters “we’re looking at that,” and “we’ll make a determination … over the next few weeks.”
Trump turned to Attorney General Pam Bondi and asked about the deadline for making a final decision regarding a proposal to change cannabis’ classification from Schedule I to Schedule III drugs under the Controlled Substances Act.
This current process of rescheduling, which was initiated under Joe Biden as president, is a result Stay The case was brought by an administrative law judge, now retired, in January. It has been on hold since then pending the outcome of an interim appeal.
Trump’s administration can decide whether to continue the hearing process with a newly appointed Drug Enforcement Administration (DEA), move on to a fast-tracked final rule by moving forward without the existing proposed rule and bypassing the hearing, begin from scratch and conduct a fresh scientific and medicine review within the U.S. Department of Health and Human Services or scrap the entire reform package.
Taken the No. 2 in CBT’s One of the 10 most popular articles in this month’s list was an article about U.S. House Rep. Greg Steube. Filing legislation to reclassify cannabis to a Schedule III substance—the Marijuana 1-to-3 Act—the day after Trump’s comments.
Steube The following are some of the ways to get in touch with each other. It is absurd that marijuana is classified less strictly than cocaine.
Some of the other articles readers were not willing to miss in August include those about the Texas Senate нормируте сери Massachusetts’ AYR Wellness has introduced a bill that would ban the use of hemp THC during a special second session. A well-known attorney reveals that he was a thief alerted New York’s cannabis regulators realized more than a decade ago that their buffer zone measurements between schools and dispensaries were incorrect.
Don’t miss out on our Top 10 stories After August 2025,
Cannabis Law Resources for Poland
Browse essential legal pages on cannabis sales and cultivation in Poland. You can use these resources to learn about the requirements for certifications, permissions and compliance.
-
Polish News Registration and Interests of Cannabis Businesses
-
Permissions for Cannabis Sales in Poland
-
Authorization for Importing or Manufacturing Medical Products
-
Permission for Manufacturing or Importing Medical Products
-
Certificate of Good Manufacturing Practices (GMP)
-
Registration of Medical Products in Poland